Skip to main content

01.12.2017 | Research article | Ausgabe 1/2017 Open Access

BMC Women's Health 1/2017

The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review

BMC Women's Health > Ausgabe 1/2017
Tasneem Siyam, Sue Ross, Sandra Campbell, Dean T. Eurich, Nesé Yuksel
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12905-017-0370-6) contains supplementary material, which is available to authorized users.



It is unclear if the use of hormone therapy (HT) in carriers of BRCA mutations improves the quality of life (QOL) without increasing the risk of breast cancer following a risk-reducing salpingo-oophorectomy (RRSO). Our objective was to assess the effect of HT on QOL and breast cancer risk, after RRSO.


We searched MEDLINE, EMBASE, CINHAL, and others, from inception to July 22, 2016, to identify relevant studies. Two reviewers independently screened identified records for controlled trials and observational studies that addressed the effect of HT on QOL and breast cancer risk in women with BRCA mutations, post RRSO. Two reviewers independently extracted data on populations, interventions, comparators, outcomes, and methodological quality. Studies addressing the same outcome were synthesized using written evidence summaries or tables.


Of the 1,059 records identified, 13 met our inclusion criteria. All studies were observational. Six studies assessed the effect on QOL. Of these, 3 showed improvement in QOL with HT use. The risk of breast cancer was evaluated in 4 studies. The mean duration of follow-up was 2.6 years (range 0.1-19.1). The risk of breast cancer did not change with HT use in all 4 studies.


Cumulative evidence from our review suggests that short-term HT use following RRSO improves QOL. The effect on breast cancer risk is still unclear. There are too few long-term studies to draw any strong conclusions. The need for future well-designed RCTs for more established evidence is imperative.
Additional file 1: A Search Strategy for Electronic Bibliographic Databases. The document provides a detailed account of the search strategy implemented by an expert searcher (SC) in a variety of electronic databases including MEDLINE, EMBASE, CINAHL, Proquest Dissertations and Theses, SCOPUS, LILACS, PsycINFO, and Cochrane Library. The search was initially performed in February/March 2014 and updated in March 2016. (DOCX 354 kb)
Additional file 2: A Search Strategy for Grey Literature: An Update. The document provides an update of the grey literature search performed in July, 2016, on SCOPUS, Proquest Dissertations and Theses, Clinical trial registries, Web of Science, and Google Scholar. (DOCX 22 kb)
Additional file 3: The Effect of Hormone Therapy on Quality of Life and Breast Cancer Risk After Risk-Reducing Salpingo-oophorectomy: Meta-analyses of Pooled studies. The document provides a written description of the methods and the results of the meta-analyses conducted in our study. (DOCX 39 kb)
Additional file 4: The results of full-text screening of eligible articles and the reason for exclusion whenever this may apply. (DOCX 19 kb)
Additional file 5: A Checklist summarizing compliance with MOOSE guidelines. The attached document is a checklist highlighting the compliance of our systematic review with the quality criteria specified by MOOSE guidelines. (DOC 27 kb)
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

BMC Women's Health 1/2017 Zur Ausgabe

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Meistgelesene Bücher aus dem Fachgebiet

2014 | Buch

Perikonzeptionelle Frauenheilkunde

Fertilitätserhalt, Prävention und Management von Schwangerschaftsrisiken

Ein Praxisbuch für alle, die in der Beratung und Betreuung von Schwangeren und Paaren mit Kinderwunsch tätig sind. Die Herausgeber und Autoren haben alle wichtigen Informationen zusammengetragen, um Frauen sicher zu beraten, zu betreuen und kompetent Verantwortung zu übernehmen.

Christian Gnoth, Peter Mallmann

2019 | Buch

Praxisbuch Gynäkologische Onkologie

Dieses kompakte und praxisrelevante Standardwerk richtet sich alle Ärzte in Klinik und Praxis, die Patientinnen mit bösartigen Tumoren des Genitales und der Mamma behandeln. Die 5. Auflage wurde komplett aktualisiert und auf der Basis …

Prof. Dr. Edgar Petru, Dr. Daniel Fink, Prof. Dr. Ossi R. Köchli, Prof. Dr. Sibylle Loibl

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Gynäkologie und bleiben Sie gut informiert – ganz bequem per eMail.